Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Buspirone for Early Satiety and Symptoms of Gastroparesis: A Multicenter, Randomized, Placebo-Controlled, Double-Masked Trial (BESST)

NCT03587142 is registered in ClinicalTrials.gov with Johns Hopkins Bloomberg School of Public Health as lead sponsor.

NCT NCT03587142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03587142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Buspirone for Early Satiety and Symptoms of Gastroparesis: A Multicenter, Randomized, Placebo-Controlled, Double-Masked Trial (BESST)
Lead sponsor
Johns Hopkins Bloomberg School of Public Health
Phase
Phase 2
Overall status
Completed
Start date
August 27, 2019
Completion date
April 30, 2022
Enrollment
96 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

gastroparesis